Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
---|---|---|---|---|---|---|
SC 13D/A | 2024-02-27 | SUMMER ROAD LLC | OCULAR THERAPEUTIX, INC | 14,360,633 | 9.4% | EDGAR |
SC 13G/A | 2024-02-14 | Opaleye Management Inc. | OCULAR THERAPEUTIX, INC | 6,070,000 | 5.5% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | OCULAR THERAPEUTIX, INC | 5,118,102 | 4.5% | EDGAR |
SC 13G/A | 2024-01-31 | BlackRock Inc. | OCULAR THERAPEUTIX, INC | 5,761,533 | 5.2% | EDGAR |
SC 13G | 2023-12-28 | Venrock Healthcare Capital Partners III, L.P. | OCULAR THERAPEUTIX, INC | 7,775,760 | 6.8% | EDGAR |
SC 13G | 2023-12-22 | Deep Track Capital, LP | OCULAR THERAPEUTIX, INC | 9,230,769 | 8.4% | EDGAR |
SC 13D/A | 2023-12-18 | SUMMER ROAD LLC | OCULAR THERAPEUTIX, INC | 13,429,782 | 11.6% | EDGAR |
SC 13G/A | 2023-02-13 | Opaleye Management Inc. | OCULAR THERAPEUTIX, INC | 6,075,000 | 7.9% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | OCULAR THERAPEUTIX, INC | 3,976,853 | 5.2% | EDGAR |
SC 13G/A | 2023-02-01 | BlackRock Inc. | OCULAR THERAPEUTIX, INC | 4,952,737 | 6.4% | EDGAR |
SC 13G | 2022-02-10 | VANGUARD GROUP INC | OCULAR THERAPEUTIX, INC | 4,079,023 | 5.3% | EDGAR |
SC 13G/A | 2022-02-03 | BlackRock Inc. | OCULAR THERAPEUTIX, INC | 5,122,835 | 6.7% | EDGAR |
SC 13G/A | 2022-02-01 | Opaleye Management Inc. | OCULAR THERAPEUTIX, INC | 5,974,800 | 7.8% | EDGAR |
SC 13G/A | 2021-02-12 | Opaleye Management Inc. | OCULAR THERAPEUTIX, INC | 9 | 11.0% | EDGAR |
SC 13G | 2021-02-02 | BlackRock Inc. | OCULAR THERAPEUTIX, INC | 5,512,264 | 7.3% | EDGAR |
SC 13G/A | 2020-06-09 | BlackRock Inc. | OCULAR THERAPEUTIX, INC | 3,006,167 | 4.8% | EDGAR |
SC 13D/A | 2020-05-21 | SUMMER ROAD LLC | OCULAR THERAPEUTIX, INC | 11,387,656 | 17.0% | EDGAR |
SC 13D/A | 2020-03-25 | SUMMER ROAD LLC | OCULAR THERAPEUTIX, INC | 11,024,020 | 18.9% | EDGAR |
SC 13G/A | 2020-02-14 | Versant Side Fund III, L.P. | OCULAR THERAPEUTIX, INC | 13,007 | 0.1% | EDGAR |
SC 13G/A | 2020-02-10 | Man Group plc | OCULAR THERAPEUTIX, INC | 760,490 | 1.6% | EDGAR |